NHE-6 inhibitors belong to a distinct chemical class characterized by their ability to selectively target and modulate the activity of the sodium/hydrogen exchanger isoform 6 (NHE-6). The sodium/hydrogen exchanger family, of which NHE-6 is a member, plays a crucial role in cellular ion homeostasis by facilitating the exchange of sodium ions for protons across cell membranes. NHE-6, specifically, is predominantly expressed in endosomal compartments within cells and is involved in regulating the pH balance within these intracellular organelles. This isoform has garnered attention due to its implication in various physiological processes, including endosomal trafficking and membrane protein sorting. Inhibitors of NHE-6 are designed to selectively bind to the active site of the exchanger, thereby modulating its function and influencing intracellular pH dynamics.
NHE-6 inhibitors exhibit a specific configuration that enables them to interact with the targeted isoform, disrupting its normal function without affecting other members of the sodium/hydrogen exchanger family. The development of these inhibitors involves a detailed understanding of the molecular mechanisms underlying NHE-6 activity and the identification of key binding sites that can be exploited for pharmacological intervention. Researchers aim to refine the selectivity and potency of NHE-6 inhibitors to enable precise modulation of endosomal pH, shedding light on the intricacies of cellular processes dependent on endosomal acidification. As investigations into the physiological roles of NHE-6 continue, the development of specific inhibitors holds promise for unraveling novel cellular pathways and functions associated with this isoform.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Amiloride | 2609-46-3 | sc-337527 | 1 g | $290.00 | 7 | |
Blocks sodium channels and sodium/hydrogen exchangers, altering the ion balance and pH regulation. | ||||||
5-(N-Ethyl-N-isopropyl)-Amiloride | 1154-25-2 | sc-202458 | 5 mg | $102.00 | 20 | |
More selective amiloride derivative that inhibits sodium/hydrogen exchangers with higher affinity. | ||||||
Cariporide | 159138-80-4 | sc-337619A sc-337619 | 10 mg 100 mg | $85.00 $715.00 | 31 | |
Selective NHE-1 inhibitor that may indirectly impact NHE-6 by modulating overall ion homeostasis. | ||||||
Amiloride, 5-(N,N-Dimethyl)-, hydrochloride | 2235-97-4 | sc-202459 | 5 mg | $230.00 | 7 | |
Amiloride derivative that inhibits sodium/hydrogen exchangers and may affect cellular pH levels. | ||||||
Zoniporide hydrochloride | 241800-98-6 (free base) | sc-476222 sc-476222A | 10 mg 50 mg | $189.00 $787.00 | ||
Selective NHE-1 inhibitor that could indirectly affect the activity of NHE-6. | ||||||
Benzamil•HCl | 161804-20-2 | sc-201070 | 50 mg | $195.00 | 1 | |
Blocks sodium channels and sodium/hydrogen exchangers, potentially affecting pH regulation. | ||||||
5-(N,N-Hexamethylene)amiloride | 1428-95-1 | sc-239021 | 25 mg | $100.00 | 2 | |
Inhibits sodium/hydrogen exchangers and could alter the activity of NHE-6 by changing ion gradients. | ||||||
Dehydroabietic acid | 1740-19-8 | sc-499572B sc-499572C sc-499572 sc-499572A sc-499572D sc-499572E | 1 mg 50 mg 100 mg 250 mg 500 mg 1 g | $216.00 $305.00 $394.00 $689.00 $1480.00 $2449.00 | 3 | |
Selective NHE-3 inhibitor that might influence NHE-6 activity indirectly. | ||||||
KR-32568 | 852146-73-7 | sc-252934 | 5 mg | $160.00 | ||
A compound that inhibits NHE-1 and potentially impacts NHE-6 indirectly. | ||||||